Portnoy says, “It’s been a long time since we’ve had a breakthrough in small cell lung cancer (#SCLC), and we are finally seeing some real concrete improvements in survival with first-line therapy and with those who have progressed on first line therapy. After years of heartbreak and minimal improvement, we’re beginning to see these breakthroughs happen.”
Dr. David Portnoy talks with OncLive about immunotherapy breakthroughs in SCLC. Click to read more!